Advertisement
Screener

CORMEDIX INC. (CRMD) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

CORMEDIX INC. Investing Cash Flow

CORMEDIX INC. (CRMD) reported Investing Cash Flow of $2.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13

  • CORMEDIX INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$561.00K.
  • CORMEDIX INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $2.96M.
  • CORMEDIX INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $3.30M.
  • CORMEDIX INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$291.32M, a 4708.49% decline year-over-year.
  • CORMEDIX INC. net cash provided by (used in) investing activities for fiscal 2025 was -$308.43M, a 1552.73% decline from fiscal 2024.
  • CORMEDIX INC. net cash provided by (used in) investing activities for fiscal 2024 was $21.23M.
  • CORMEDIX INC. net cash provided by (used in) investing activities for fiscal 2023 was -$17.06M.
  • CORMEDIX INC. net cash provided by (used in) investing activities for fiscal 2022 was -$3.71M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 3 month as first filedNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 6 month as first filedNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 monthNet Cash Provided by (Used in) Investing Activities 12 month as first filedNet Cash Provided by (Used in) Investing Activities 59 monthNet Cash Provided by (Used in) Investing Activities 62 monthNet Cash Provided by (Used in) Investing Activities 65 monthNet Cash Provided by (Used in) Investing Activities 68 monthNet Cash Provided by (Used in) Investing Activities 71 monthNet Cash Provided by (Used in) Investing Activities 74 monthNet Cash Provided by (Used in) Investing Activities 77 monthNet Cash Provided by (Used in) Investing Activities 80 monthNet Cash Provided by (Used in) Investing Activities 83 monthNet Cash Provided by (Used in) Investing Activities 89 monthNet Cash Provided by (Used in) Investing Activities 92 month
2026-06-30-$561.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$2.40M
10-Q · filed 2026-08-13
$5.70M
derived: sum of 3 quarters · filed 2026-08-13
-$285.62M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$2.96M
10-Q · filed 2026-05-14
$6.26M
derived: sum of 2 quarters · filed 2026-05-14
-$285.06M
derived: sum of 3 quarters · filed 2026-05-14
-$305.27M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$3.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
-$288.02M
derived: sum of 2 quarters · filed 2026-03-05
-$308.24M
derived: sum of 3 quarters · filed 2026-08-13
-$308.43M
10-K · filed 2026-03-05
2025-09-30-$291.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$311.53M
derived: sum of 2 quarters · filed 2026-08-13
-$311.73M
10-Q · filed 2025-11-12
-$312.03M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$20.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$20.41M
10-Q · filed 2026-08-13
-$20.41M
10-Q · filed 2025-08-07
-$20.71M
derived: sum of 3 quarters · filed 2026-08-13
-$14.39M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$195.00K
10-Q · filed 2026-05-14
-$194.82K
10-Q · filed 2025-05-06
-$498.87K
derived: sum of 2 quarters · filed 2026-05-14
$5.82M
derived: sum of 3 quarters · filed 2026-05-14
$12.09M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$303.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$6.02M
derived: sum of 2 quarters · filed 2026-03-05
$12.29M
derived: sum of 3 quarters · filed 2026-03-05
$21.23M
10-K · filed 2026-03-05
$21.23M
10-K · filed 2025-03-25
2024-09-30$6.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$12.59M
derived: sum of 2 quarters · filed 2025-11-12
$21.53M
10-Q · filed 2025-11-12
$22.13M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$6.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$15.21M
10-Q · filed 2025-08-07
$15.81M
derived: sum of 3 quarters · filed 2025-08-07
$15.22M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$8.94M
10-Q · filed 2025-05-06
$9.54M
derived: sum of 2 quarters · filed 2025-05-06
$8.96M
derived: sum of 3 quarters · filed 2025-05-06
$6.57M
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31$597.79K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25
$10.93K
derived: sum of 2 quarters · filed 2025-03-25
-$2.37M
derived: sum of 3 quarters · filed 2025-03-25
-$17.06M
10-K · filed 2025-03-25
2023-09-30-$586.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
-$2.97M
derived: sum of 2 quarters · filed 2024-10-30
-$17.66M
10-Q · filed 2024-10-30
-$17.66M
derived: sum of 4 quarters · filed 2024-10-30
2023-06-30-$2.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
-$17.07M
10-Q · filed 2024-08-14
-$17.07M
derived: sum of 3 quarters · filed 2024-08-14
-$17.19M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$14.69M
10-Q · filed 2024-05-09
-$14.69M
derived: sum of 2 quarters · filed 2024-05-09
-$14.80M
derived: sum of 3 quarters · filed 2024-05-09
-$14.21M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$1.86K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
-$116.14K
derived: sum of 2 quarters · filed 2024-03-12
$478.30K
derived: sum of 3 quarters · filed 2024-03-12
-$3.71M
10-K · filed 2024-03-12
2022-09-30-$114.28K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$480.16K
derived: sum of 2 quarters · filed 2023-11-14
-$3.71M
10-Q · filed 2023-11-14
-$10.84M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$594.44K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$3.59M
10-Q · filed 2023-08-08
-$10.72M
derived: sum of 3 quarters · filed 2023-08-08
-$11.99M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$4.19M
10-Q · filed 2023-05-15
-$11.32M
derived: sum of 2 quarters · filed 2023-05-15
-$12.59M
derived: sum of 3 quarters · filed 2023-05-15
-$12.80M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$7.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$8.40M
derived: sum of 2 quarters · filed 2023-03-30
-$8.61M
derived: sum of 3 quarters · filed 2023-03-30
-$9.13M
10-K · filed 2023-03-30
2021-09-30-$1.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$1.48M
derived: sum of 2 quarters · filed 2022-11-10
-$2.01M
10-Q · filed 2022-11-10
-$3.85M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$208.28K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$734.29K
10-Q · filed 2022-08-11
-$2.58M
derived: sum of 3 quarters · filed 2022-08-11
$661.49K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$526.02K
10-Q · filed 2022-05-12
-$2.37M
derived: sum of 2 quarters · filed 2022-05-12
$869.77K
derived: sum of 3 quarters · filed 2022-05-12
$5.91M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$1.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$1.40M
derived: sum of 2 quarters · filed 2022-03-29
$6.44M
derived: sum of 3 quarters · filed 2022-03-29
$7.43M
10-K · filed 2022-03-29
2020-09-30$3.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$8.29M
derived: sum of 2 quarters · filed 2021-11-09
$9.27M
10-Q · filed 2021-11-09
$9.57M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$5.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$6.03M
10-Q · filed 2021-08-12
$6.33M
derived: sum of 3 quarters · filed 2021-08-12
$5.85M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$985.42K
10-Q · filed 2021-05-13
$1.28M
derived: sum of 2 quarters · filed 2021-05-13
$804.49K
derived: sum of 3 quarters · filed 2021-05-13
-$3.07M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$296.26K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
-$180.93K
derived: sum of 2 quarters · filed 2021-03-30
-$4.06M
derived: sum of 3 quarters · filed 2021-03-30
-$12.02M
10-K · filed 2021-03-30
2019-09-30-$477.19K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$4.35M
derived: sum of 2 quarters · filed 2020-11-05
-$12.32M
10-Q · filed 2020-11-05
-$12.32M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$3.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$11.84M
10-Q · filed 2020-08-10
-$11.84M
derived: sum of 3 quarters · filed 2020-08-10
-$11.85M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31-$7.96M
10-Q · filed 2020-05-11
-$7.96M
derived: sum of 2 quarters · filed 2020-05-11
-$7.98M
derived: sum of 3 quarters · filed 2020-05-11
-$7.98M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$109.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$10.56K
derived: sum of 2 quarters · filed 2020-03-16
-$10.56K
derived: sum of 3 quarters · filed 2020-03-16
$1.56M
10-K · filed 2020-03-16
2018-09-30-$10.67K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$10.67K
derived: sum of 2 quarters · filed 2019-11-14
$1.56M
10-Q · filed 2019-11-14
$6.62M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$1.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.57M
10-Q · filed 2019-08-14
$6.63M
derived: sum of 3 quarters · filed 2019-08-14
$10.70M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$1.57M
10-Q · filed 2019-05-13
$6.63M
derived: sum of 2 quarters · filed 2019-05-29
$10.70M
derived: sum of 3 quarters · filed 2019-05-29
$6.77M
derived: sum of 4 quarters · filed 2019-05-29
2017-12-31$5.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-29
$9.14M
derived: sum of 2 quarters · filed 2019-05-29
$5.20M
derived: sum of 3 quarters · filed 2019-05-29
$10.36M
10-K · filed 2019-05-29
2017-09-30$4.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$132.91K
derived: sum of 2 quarters · filed 2018-11-14
$5.29M
10-Q · filed 2018-11-14
$10.01M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$3.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$1.22M
10-Q · filed 2018-08-14
$5.94M
derived: sum of 3 quarters · filed 2018-08-14
$5.64M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$5.16M
10-Q · filed 2018-05-15
$9.87M
derived: sum of 2 quarters · filed 2018-05-15
$9.58M
derived: sum of 3 quarters · filed 2018-05-15
$10.03M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$4.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19
$4.42M
derived: sum of 2 quarters · filed 2018-03-19
$4.87M
derived: sum of 3 quarters · filed 2018-03-19
$11.42M
10-K · filed 2018-03-19
2016-09-30-$295.80K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$155.96K
derived: sum of 2 quarters · filed 2017-11-09
$6.70M
10-Q · filed 2017-11-09
$6.71M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$451.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$7.00M
10-Q · filed 2017-08-09
$7.01M
derived: sum of 3 quarters · filed 2017-08-09
-$3.21M
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$6.55M
10-Q · filed 2017-05-10
$6.56M
derived: sum of 2 quarters · filed 2017-05-10
-$3.66M
derived: sum of 3 quarters · filed 2017-05-10
-$17.05M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$9.99K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$10.21M
derived: sum of 2 quarters · filed 2017-03-16
-$23.60M
derived: sum of 3 quarters · filed 2017-03-16
-$23.61M
10-K · filed 2017-03-16
2015-09-30-$10.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$23.61M
derived: sum of 2 quarters · filed 2016-11-09
-$23.62M
10-Q · filed 2016-11-09
-$23.62M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30-$13.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$13.40M
10-Q · filed 2016-08-04
-$13.40M
derived: sum of 3 quarters · filed 2017-03-16
-$13.40M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31-$12.94K
10-Q · filed 2016-05-10
-$12.45K
derived: sum of 2 quarters · filed 2017-03-16
-$18.73K
derived: sum of 3 quarters · filed 2017-03-16
-$38.35K
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$496.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$5.79K
derived: sum of 2 quarters · filed 2017-03-16
-$25.40K
derived: sum of 3 quarters · filed 2017-03-16
-$25.40K
10-K · filed 2017-03-16
2014-09-30-$6.29K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$25.90K
derived: sum of 2 quarters · filed 2015-11-12
-$25.90K
10-Q · filed 2015-11-12
-$61.58K
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30-$19.61K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$19.61K
10-Q · filed 2015-08-06
-$55.30K
derived: sum of 3 quarters · filed 2015-08-06
-$55.30K
derived: sum of 4 quarters · filed 2015-08-06
2014-03-31$0.00
10-Q · filed 2015-05-07
-$35.68K
derived: sum of 2 quarters · filed 2015-05-07
-$35.68K
derived: sum of 3 quarters · filed 2015-05-07
-$35.68K
derived: sum of 4 quarters · filed 2015-05-07
-$97.39K
10-Q · filed 2014-05-15
2013-12-31-$35.68K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
-$35.68K
derived: sum of 2 quarters · filed 2015-03-12
-$35.68K
derived: sum of 3 quarters · filed 2015-03-12
-$35.68K
10-K · filed 2015-03-12
-$97.39K
10-K · filed 2014-03-31
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$0.00
derived: sum of 2 quarters · filed 2014-11-13
$0.00
10-Q · filed 2014-11-13
$0.00
derived: sum of 4 quarters · filed 2014-11-13
-$61.71K
10-Q/A · filed 2014-03-04
2013-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$0.00
10-Q · filed 2014-08-14
$0.00
derived: sum of 3 quarters · filed 2014-08-14
$0.00
derived: sum of 4 quarters · filed 2014-08-14
-$61.71K
10-Q/A · filed 2014-03-04
2013-03-31$0.00
10-Q · filed 2014-05-15
$0.00
derived: sum of 2 quarters · filed 2014-05-15
$0.00
derived: sum of 3 quarters · filed 2014-05-15
$0.00
derived: sum of 4 quarters · filed 2014-05-15
-$61.71K
10-Q/A · filed 2014-03-04
2012-12-31$0.00
derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-31
$0.00
derived: sum of 2 quarters · filed 2014-03-31
$0.00
derived: sum of 3 quarters · filed 2014-03-31
$0.00
10-K · filed 2014-03-31
-$61.71K
10-K/A · filed 2014-03-04
2012-09-30$0.00
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2014-03-04
$0.00
derived: sum of 2 quarters · filed 2014-03-04
$0.00
10-Q/A · filed 2014-03-04
$0.00
derived: sum of 4 quarters · filed 2014-03-04
-$61.71K
10-Q/A · filed 2013-03-27
2012-06-30$0.00
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2014-03-04
$0.00
10-Q/A · filed 2014-03-04
$0.00
derived: sum of 3 quarters · filed 2014-03-04
$0.00
derived: sum of 4 quarters · filed 2014-03-04
-$61.71K
10-Q/A · filed 2012-09-06
2012-03-31$0.00
10-Q/A · filed 2014-03-04
$0.00
derived: sum of 2 quarters · filed 2014-03-04
$0.00
derived: sum of 3 quarters · filed 2014-03-04
-$61.71K
10-Q · filed 2012-05-15
2011-12-31$0.00
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-03-04
$0.00
derived: sum of 2 quarters · filed 2014-03-04
-$1.63K
10-K/A · filed 2014-03-04
-$61.71K
10-K/A · filed 2012-04-26
2011-09-30$0.00
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-03-27
-$1.63K
10-Q/A · filed 2013-03-27
-$61.71K
10-Q · filed 2011-11-10
2011-06-30-$1.63K
10-Q/A · filed 2012-09-06
-$61.71K
10-Q · filed 2011-08-09
2010-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-04-26
-$3.56K
derived: sum of 2 quarters · filed 2012-04-26
-$10.36K
10-K/A · filed 2012-04-26
2010-09-30-$3.56K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
-$10.36K
10-Q · filed 2011-11-10
2010-06-30-$6.80K
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61